Faecalibacterium prausnitzii is a primary butyrate-producing bacterium that exerts anti-inflammatory and immunomodulatory effects through butyrate-NF-κB signalling and tight-junction reinforcement, conferring protection against metabolic disorders such as obesity, diabetes, and hypertension. Here, NFKB1 is linked to hypertensive disorder.